MARKET

VYNE

VYNE

Vyne Therapeutics Inc
NASDAQ
0.6475
-0.0008
-0.12%
After Hours: 0.6350 -0.0125 -1.93% 19:59 06/29 EDT
OPEN
0.6400
PREV CLOSE
0.6483
HIGH
0.6600
LOW
0.6300
VOLUME
117.00K
TURNOVER
--
52 WEEK HIGH
1.960
52 WEEK LOW
0.2805
MARKET CAP
21.62M
P/E (TTM)
-1.2914
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VYNE last week (0622-0626)?
Weekly Report · 22h ago
Weekly Report: what happened at VYNE last week (0615-0619)?
Weekly Report · 06/22 09:00
Weekly Report: what happened at VYNE last week (0608-0612)?
Weekly Report · 06/15 09:00
These healthcare stocks are combining strong gains with reasonable prices
Seeking Alpha · 06/12 10:38
Weekly Report: what happened at VYNE last week (0601-0605)?
Weekly Report · 06/08 09:00
Vyne Therapeutics publishes investor presentation on Yarrow Bioscience, YB-101 anti-TSHR program for Graves' disease, thyroid eye disease
PUBT · 06/02 13:00
Weekly Report: what happened at VYNE last week (0525-0529)?
Weekly Report · 06/01 09:00
Weekly Report: what happened at VYNE last week (0518-0522)?
Weekly Report · 05/25 09:00
More
About VYNE
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. It is developing VYN202, an oral, small molecule BD2-selective BET inhibitor. VYN202 is an oral, small molecule BD2-selective BET inhibitor that has been designed to achieve potential class-leading potency and selectivity for BD2 vs. BD1. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating.

Webull offers Vyne Therapeutics Inc stock information, including NASDAQ: VYNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYNE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYNE stock methods without spending real money on the virtual paper trading platform.